Drug Shortage Report for NALOXONE HCL INJECTION - 1MG/ML USP

Last updated on 2019-06-28 History
Report ID 80573
Drug Identification Number 02148714
Brand name NALOXONE HCL INJECTION - 1MG/ML USP
Common or Proper name NALOXONE HCl Inj
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 1MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10X2ml
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2019-04-05
Estimated end date 2019-06-17
Actual end date 2019-06-19
Shortage status Resolved
Updated date 2019-06-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-06-28 English Compare
v8 2019-04-12 French Compare
v7 2019-04-12 English Compare
v6 2019-04-12 English Compare
v5 2019-04-11 French Compare
v4 2019-04-11 English Compare
v3 2019-04-06 English Compare
v2 2019-04-05 French Compare
v1 2019-04-05 English Compare

Showing 1 to 9 of 9